Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use RUCONEST ® safely and effectively. See full prescribing information for RUCONEST. RUCONEST (C1 esterase inhibitor [recombinant]) For Intravenous Use, Lyophilized Powder For Reconstitution Initial U.S. Approval: 2014
Medication labelWhy this: Advisory · dailymed-prescription
RUCONEST is a C1 esterase inhibitor [recombinant] indicated for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema (HAE). Limitation of Use: Effectiveness was not established in HAE patients with laryngeal attacks.
- generic_name
- c1 esterase inhibitor recombinant
- product_names
- c1 esterase inhibitor recombinant
- ndc
- 71274-350, 71274-350-01, 71274-350-02
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en